Skip to main content
. 2021 May 5;2021:8898919. doi: 10.1155/2021/8898919

Table 6.

Matrix metalloproteinase (MMP-2) activation in myocardial tissue forty-eight hours after injection of doxorubicin.

C (n = 6) GT (n = 6) D (n = 6) DGT (n = 6) P i P gt P d
MMP-2at 9412 ± 6060 7690 ± 3939 11413 ± 10306 8468 ± 12171 0,85 0,49 0,68
MMP-2int. 21907 ± 10304 23576 ± 11532 54553 ± 26211 32163 ± 32206 0,16 0,23 0,02
MMP-2inat 35800 ± 21485 34116 ± 32446 48421 ± 29076 48677 ± 32498 0,93 0,95 0,24
MMP-2at/inat 2, 41 ± 0, 62 1, 14 ± 0, 74 1, 94 ± 1, 76 1, 11 ± 1, 80 0,81 0,79 0,72
MMP-2int/inat 0, 89 ± 0, 62 0, 86 ± 0, 43 1, 94 ± 1, 58 0, 57 ± 0, 21 0,09 0,13 0,53

Groups: C: control; GT: green tea; D: doxorubicin; DGT: doxorubicin+green tea. MMP-2a: active matrix metalloproteinase; MMP-2int: intermediary matrix metalloproteinase; MMP-2inat: inactive matrix metalloproteinase. Values are expressed in mean ± standard deviation. P value: two-way ANOVA. Pi: P value of interaction; Pgt: P value of green tea; Pd: P value of doxorubicin. When we observed the interaction between factors (Pi < 0, 05), we compared the groups. MMP-2int: D ≠ C, D ≠ GT, DGT ≠ C, and DGT ≠ GT.